Who’s In Control? Thoratec, Investigators Discuss Access To NIH-Funded Data

Thoratec is in negotiations with NIH to restrict access to control group data from the REMATCH randomized trial of the HeartMate VE upon the study's completion

More from Archive

More from Medtech Insight